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Malnutrition occurs frequently in patients with cancer of the gastrointestinal (GI) or head and neck area and can lead to negative
outcomes. The aim of this study is to determine the impact of early and intensive nutrition intervention (NI) on body weight, body
composition, nutritional status, global quality of life (QoL) and physical function compared to usual practice in oncology outpatients
receiving radiotherapy to the GI or head and neck area. Outpatients commencing at least 20 fractions of radiotherapy to the GI or
head and neck area were randomised to receive intensive, individualised nutrition counselling by a dietitian using a standard protocol
and oral supplements if required, or the usual practice of the centre (general advice and nutrition booklet). Outcome parameters
were measured at baseline and 4, 8 and 12 weeks after commencing radiotherapy using valid and reliable tools. A total of 60 patients
(51M:9F; mean age 61.9714.0 years) were randomised to receive either NI (n¼29) or usual care (UC) (n¼31). The NI group had
statistically smaller deteriorations in weight (Po0.001), nutritional status (P¼0.020) and global QoL (P¼0.009) compared with
those receiving UC. Clinically, but not statistically significant differences in fat-free mass were observed between the groups
(P¼0.195). Early and intensive NI appears beneficial in terms of minimising weight loss, deterioration in nutritional status, global QoL
and physical function in oncology outpatients receiving radiotherapy to the GI or head and neck area. Weight maintenance in this
population leads to beneficial outcomes and suggests that this, rather than weight gain, may be a more appropriate aim of NI.
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The incidence of malnutrition in patients with cancer ranges from
40 to 80% (Ollenschlager et al, 1991) and most frequently occurs in
patients with cancer of the gastrointestinal (GI) or head and neck
area (Lees, 1999). Malnutrition increases the risk of infections,
treatment toxicity and health-care costs and decreases response to
treatment, quality of life (QoL) and life expectancy (Nitenberg and
Raynard, 2000).
Radiotherapy treatment can cause side effects that may limit
oral intake and lead to weight loss. It has been suggested that
adequate nutrition support during radiotherapy can decrease the
impact of side effects, minimise weight loss, improve QoL and help
patients to recover from the radiotherapy more quickly (Polisena,
2000, p. 70). There is little evidence based on clinical research to
support this. Those studies that have investigated nutritional
problems in oncology patients often draw attention to the links
between nutritional status and outcomes. Many focus on
biochemical and clinical issues and overlook the service delivery
and more qualitative aspects of care such as QoL.
Many of the studies investigating nutrition support in the
oncology setting have focused on the effect of enteral and/or
parenteral nutrition on patient outcomes with mixed outcomes.
The effects on outcomes were mixed. However, many had study
design limitations including: no controlled allocation (Barber et al,
1998); inadequate nutrition support in terms of frequency of
contact with the dietitian (Evans et al, 1987); small sample sizes
(Wigmore et al, 1996); differing nutrition regimens and lack of
standardisation of oral diets; and excluding those subjects who
were lost due to attrition (Ovesen et al, 1993).
Traditionally, body weight and body mass index (BMI) have
been used as outcome measures in dietetic practice, but these
measures do not reflect the body composition changes that may
occur during chronic disease such as cancer. It is the loss of fat-
free mass (FFM) that is responsible for the reduced functional
status, increased mortality and other negative outcomes associated
with malnutrition (Tchekmedyian et al, 1992). Body fat is easier to
gain than FFM, so studies that show improved body weight may
not translate into reductions in morbidity or improvements in
functional status.
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lThe aim of this study was to determine the impact of early and
intensive nutrition intervention (NI) on a range of outcomes
including body weight, body composition, nutritional status,
global QoL and physical function compared to usual practice in
oncology outpatients receiving radiotherapy to the GI or head and
neck area.
SUBJECTS AND METHODS
Ethical approval was granted for this study from the Queensland
University of Technology University Human Research Ethics
Committee and The Wesley Hospital Multidisciplinary Ethics
Committee and informed consent was obtained from all partici-
pants. A prospective, randomised-controlled trial was conducted.
All outpatients commencing at least 20 fractions of radiotherapy to
the GI or head and neck area at a private Australian radiation-
oncology facility during a 12-month period were eligible for
inclusion. Persons were deemed ineligible if they were: under the
age of 18 years; hospital inpatients for greater than 5 days;
receiving enteral or parenteral nutrition; or not able to provide
informed consent.
In all, 78 consecutive patients were eligible for inclusion. Of
these, 60 patients (51M:9F; mean age 61.9 714.0 years) consented
to the study and were randomised to receive either NI (n¼29) or
UC (n¼31). A total of 88% of subjects were receiving radiotherapy
to the head and neck (15% parotid, 13% oesophagus, 13% neck,
10% mouth, 8% vocal cords and 29% other head and neck areas)
and 12% of patients were receiving radiotherapy to the abdominal
or rectal area. In total, 47% of subjects were being treated with
postoperative radiotherapy, 3% receiving preoperative radio-
therapy and the remaining 50% received radiotherapy only and
had no plans for surgery. Subject characteristics at baseline are
presented in Table 1. According to Subjective Global Assessment
(SGA), 65.0% (n¼39) of subjects were well nourished and 35.0%
(n¼21) malnourished, of which 28.3% (n¼17) were moderately
nourished or suspected of being malnourished and 6.7% (n¼4)
were severely malnourished. Six subjects were lost to follow-up.
There were no significant differences between the types of tumour
and the fraction and dose of radiotherapy of subjects receiving NI
or UC. There were no significant differences in baseline
characteristics between subjects that were lost to follow-up and
those that completed the study.
Nutrition intervention
Patients received individualised NI in the form of regular and
intensive nutrition counselling by a dietitian, following a
predetermined standard nutrition protocol, the Medical Nutrition
Therapy (Cancer/Radiation Oncology) protocol of the American
Dietetic Association (ADA) (Gillbreath et al, 1998) for the 12-week
study. This protocol included general guidelines referring to the
time and frequency of dietitian consultations, data to be collected
during the nutrition assessment and NI strategies, but did permit
individualisation of the therapy to meet the specific needs of the
patients. Nutrition counselling by the dietitian was provided
within the first 4 days of commencing radiotherapy and weekly for
the course of radiotherapy (approximately 6 weeks) and fort-
nightly for the remainder of the study period. Telephone reviews
were conducted between nutrition counselling sessions. Individu-
ally tailored sample meal plans, recipe suggestions and hints to
minimise the side effects of the tumour and therapy were provided.
Standard patient handouts from the ADA Oncology Nutrition
Dietetic Practice Group, as well as snack and high energy and
protein exchange lists, were used. If deemed appropriate, the
dietitian would provide a weekly supply of oral nutrition
supplements for up to 3 months.
Usual care
The UC group received the UC of that centre, that is, education by
the nurses, provision of the resource ‘Understanding Nutrition – a
booklet from the Queensland Cancer Fund’ and oral nutrition
supplement samples. Compared to the NI group, those receiving
UC received less nutrition assessment, no individualisation of
nutrition advice and less follow-up. Patients receiving radio-
therapy to the head and neck area were automatically referred to
an outpatient dietitian. Those receiving radiotherapy to areas other
than the head and neck could also request a referral to the
outpatient dietitian. These patients received the UC of that service,
which was a maximum of two dietetic consultations.
Data collection
The following outcomes were measured: body weight and FFM
(foot-to-foot bioelectrical impedance analysis (BIA)); nutritional
status (scored Patient-Generated-Subjective Global Assessment
(PG-SGA)); and global QoL (European Organisation for the
Research and Treatment of Cancer (EORTC) QLQ-C30). Outcomes
were assessed at the commencement of radiotherapy and 4, 8 and
12 weeks after commencing treatment.
Foot-to-foot BIA: is a recent development in BIA technology and
is so named because an electric current is induced and the voltage
drop measured via four metallic footplates situated on top of a
conventional weighing scale. We have previously shown that foot-
to-foot BIA is acceptable at the group level in measuring total body
water and, hence FFM, in oncology patients receiving radiotherapy
(Isenring et al, 2004).
Scored PG-SGA: has been developed for use in the cancer
population (Ottery, 2000, p. 12) and is an adaptation of the
validated nutrition assessment tool, SGA (Detsky et al, 1987).
Patient-Generated-Subjective Global Assessment score, correlated
with objective nutrition parameters (% weight loss, BMI), QoL,
morbidity (survival, length of stay), has a high degree of inter-rater
reproducibility and a high sensitivity and specificity when
compared with other validated nutritional assessment tools (Bauer
et al, 2002; Isenring et al, 2002). Each subject was classified as
either well nourished (SGA A), moderately nourished or suspected
of being malnourished (SGA B), or severely malnourished (SGA
C), and in addition, a total PG-SGA score was calculated. For each
component of the PG-SGA, points (0–4) are awarded depending
on the impact on nutritional status. Typical scores range from 0 to
35 with a higher score reflecting a greater risk of malnutrition and
scores X9 indicating a critical need for NI and symptom
management.
Table 1 Baseline characteristics for subjects receiving NI and UC
Variable (n) NI (29) UC (31)
Gender (M:F) 24:5 27:4
Age (years) 60.6715.6 63.3712.5
Weight (kg) 74.877.8 77.6718.2
Height (cm) 174.577.2 171.879.2
BMI (kg/m
2) 25.274.4 26.474.5
PG-SGA score 7.176.1 5.974.3
SGA-A (well nourished) 17 (59) 22 (71)
B (suspected or moderately malnourished) 9 (31) 8 (26)
C (severely malnourished) 3 (10) 1 (3)
Percentage weight loss past 6 months 2.6 (0, 20.0) 3.6 (0, 12.6)
Global QoL score 67.7718.8 75.3719.2
NI¼nutrition intervention; UC¼usual care; BMI¼body mass index; SGA¼Subjec-
Subjective Global Assessment; PG-SGA¼Patient-Generated-Subjective Global
Assessment; QoL¼quality of life; s.d.¼standard deviation. Continuous variables
presented as mean7s.d. for normally distributed variables or median (range) for data
that are not normally distributed. Categorical variables are presented as counts (%).
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lEORTC QLQ-C30 (version 3): is a validated QoL assessment tool
and was completed as described by the authors (Aaronson et al,
1993). This patient-based instrument is comprised of 30 items
making up five functional scales (physical, role, cognitive, social,
emotional), three symptom scales (fatigue, pain and nausea/
vomiting), and global health status and global QoL scales. Physical
function was also assessed using this tool. QLQ-C30 results are
linearly converted to a score out of one hundred, with a higher score
reflecting a higher QoL. Questionnaires were scored and trans-
formed using the QLQ-C30 scoring manual (Fayers et al, 1999).
Statistical analysis
All analyses were performed on an intention-to-treat basis.
Repeated measure analyses were carried out for weight, nutritional
status and global QoL using SPSS version 10, 2000 (SPSS Inc.,
Chicago, IL, USA). Weight gain or a weight loss of less than 1kg
over a 2- or 3-month period was classified as weight stable
(Rosenbaum et al, 2000). The proportion of weight stable patients
receiving either NI or UC was calculated using w
2 tests. More than
10% of the data were missing for FFM and so repeated measures
using a different mathematical modelling approach was carried out
using SUDAAN version 7.5.2A. This is a generalised estimating
equations approach that permits the inclusion of subjects with
incomplete data records. Hence, the analyses were based on 60
subjects who contributed between one and four time points of
information. Statistical significance was reported at the conven-
tional Po0.05 level (two-tailed).
RESULTS
The NI group maintained body weight over 12 weeks (mean
change¼ 0.4kg) compared with those receiving UC who had a
significantly greater deterioration in weight (mean chan-
ge¼ 4.7kg) (Po0.001) (Figure 1). Significantly more patients
in the NI group were weight stable compared with the UC group
(Table 2). Changes in FFM over time were clinically significant
with the NI group resulting in a mean gain of 0.5kg and the UC
group a mean loss of 1.4kg FFM over 12 weeks, but this difference
did not reach statistical significance (P¼0.195).
Those receiving NI had a significantly smaller deterioration in
nutritional status as measured by PG-SGA score than those
receiving UC (P¼0.02) (Figure 2). The NI group also had a
significantly smaller decrease and faster recovery in global QoL
(P¼0.009) and in physical function (P¼0.012) over time
compared with the UC group (Figures 3 and 4).
DISCUSSION
The aim of this study was to determine the impact of early and
intensive NI on a range of outcomes including body weight, body
composition, nutritional status, global QoL and functional status
compared to usual practice in oncology outpatients receiving
radiotherapy to the GI or head and neck areas.
Body weight
Treatment-related side effects of patients receiving radiotherapy to
the GI or head and neck area peak around two-thirds of the way
during radiotherapy and continue for 2 or more weeks after
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patients receiving either NI or UC.
Table 2 Proportion of weight losing and weight stable subjects receiving
either NI or UC
Group Weight stable
a Weight losing
b
NI 13 (24%) 12 (22%)
UC 6 (11%) 23 (43%)
NI¼nutrition intervention; UC¼usual care. P-value¼0.016 based on w
2 analyses.
aWeight stable¼weight gain or weight loss o1kg.
bWeight losing¼weight loss of
41kg.
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Figure 3 Mean (s.e.m.) EORTC QLQ-C30 score assessing global QoL
for 54 ambulatory radiation-oncology patients receiving either nutrition NI
or UC.
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in the current study with both NI and UC groups losing weight
between the 4- and 8-week period. However, the NI group then
regained weight. Providing intensive nutrition support with
regular follow-up helped attenuate the natural weight loss history
of treatment compared to those subjects in the UC group who
reflected the typical decreases in body weight (Figure 1). This is
confirmed by the data in Table 2, which showed that more weight
stable subjects were receiving NI and more of the weight losing
subjects were receiving UC.
The results of the current study are important because it is one
of the first randomised-controlled trials that demonstrate bene-
ficial outcomes in those receiving NI and contrasts with the
conclusions of other nutrition support trials. In a review of 11
randomised-controlled trials in patients with cancer, it was
concluded that oral nutrition supplements failed to improve
weight, body composition or functional outcomes in patients with
cancer (Stratton and Elia, 1999). Other studies have found that the
best-case scenario was slowing the rate of weight loss in patients
receiving chemotherapy despite an increase in protein and energy
intake (Evans et al, 1987; Ovesen et al, 1993). Few studies have
demonstrated the benefits of NI. A Cochrane review (Baldwin et al,
2004) investigating the impact of dietary counselling with and
without oral nutrition supplements in malnourished patients
concluded that nutrition supplements were more important than
dietary counselling in maintaining body weight, but there were
insufficient data to conclude whether the supplements decreased
morbidity and mortality.
An important limitation of these studies was that there was
insufficient description of what dietetic counselling involved: the
frequency of contact and follow-up. Capra et al (2002) suggest that
a failure to implement adequately the nutrition prescription and
monitor compliance of this prescription could be responsible for
the ‘negative’ results from dietary studies and highlights that these
studies generally overlook patient-focused outcomes such as QoL
and function status.
The suggested reasons as to why the current trial has been
successful in maintaining body weight in the NI group compared
with the UC group is the intensity and frequency of nutrition
counselling. There was also a substantial follow-up period even
after completing radiotherapy. The benefits appear to be due to the
minimisation of eating difficulties typically experienced by
patients receiving radiotherapy to the GI and head and neck area,
rather than helping cachectic patients maintain weight. Treatment
side effects, early satiety, fatigue and anorexia are possible to
ameliorate with the appropriate dietary intake (Capra et al, 2002).
Body composition
Generally, professional opinion considers changes of 0.5–1kg in
FFM to be clinically significant (Barber et al, 1999a,b). Clinically
significant differences in FFM were observed between the groups
with a mean increase in FFM of 0.4kg in the NI group vs the UC
group, which experienced a mean decrease of 1.4kg FFM. These
values are similar to that found by May et al (2002) during a
randomised-controlled trial investigating the impact of an amino-
acid-enriched oral supplement in patients with stage IV solid
tumours over 24 weeks and observed clinically significant
differences in FFM between groups (1.6070.94 vs 0.4871.08kg;
P¼0.20).
The majority of intervention trials that have shown beneficial
influences on FFM have involved specialised nutrition or
pharmacological products and have often targeted patients with
cancer cachexia (Simons et al, 1998; May et al, 2002; Fearon et al,
2003). There is limited data on the impact of early and intensive
nutrition support by way of dietetic counselling to increase
protein and energy intake and target eating problems, on body
composition.
Nutritional status
The scored PG-SGA is a valid and reliable measure of nutritional
status and allows tracking of changes in nutritional status over
short periods of time, unlike broader nutritional measures, such as
BMI (Bauer et al, 2002). Although the scored PG-SGA is widely
used as a nutritional assessment tool in oncology patients and has
been adopted by the American Dietetic Association as the standard
protocol for use in patients with cancer, there is limited data
available on the PG-SGA for comparison with this study because
few studies have used the PG-SGA as an outcome measure. This
study found that patients in the NI group had less deterioration in
nutritional status as indicated by a lower PG-SGA score compared
to the UC group.
Global QoL
Medical care is no longer evaluated solely by traditional
biomedical indicators (Niezgoda and Pater, 1993) and there is
now a focus to have a broader concept of patient outcomes such as
QoL (Cella and Cherin, 1988). The impact of nutrition on QoL has
not been well documented; however, there are several studies that
have observed poorer QoL outcomes in malnourished patients
when compared with well-nourished patients (Larsson et al, 1995;
Ohrn et al, 2001). QoL is an especially important outcome measure
for treatments that are not predicted to impact on disease
progression and survival (Sanders et al, 1998). This would include
nutrition support interventions where perceived benefits are
related to QoL and functional status rather than mortality.
For both groups global QoL was at its lowest at 4 weeks. It
appears that global QoL is negatively influenced by the side effects
that patients experience. Ravasco et al (2003) observed significant
increases in QoL in patients who were receiving radiotherapy to
the GI or head and neck area and individualised oral nutrition
support despite an increase in symptoms. From the known history
of radiation, it is reasonable to predict that global QoL would be at
its lowest points at 4 and 8 weeks. However, improvements are
already being seen in global QoL by the 8-week period, especially
in those subjects receiving NI. This may be due to adaptation
processes affecting QoL. Hagedoorn et al (2002) propose that some
patients with cancer may experience a response shift that is
defined as the change in the meaning of an individuals self-
reported QoL, for example, different points in time may have
different meanings. It may also be due to the fact that by 8 weeks,
all subjects had completed radiotherapy treatment and would be
back in their own homes. Even though experiencing some side
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leffects, not having to visit the radiation-oncology centre and being
in familiar surroundings may lead to improvements in QoL
(Hagedoorn et al, 2002).
Physical function
Change in physical function could also be responsible for a
proportion of the change in global QoL. Figure 4 shows that there
was a significant difference in physical function between the NI
and UC groups over the 12-week study. However, while the
physical function remained low in the UC group, the NI group was
experiencing some recovery. It is reasonable to hypothesise that
physical function would impact on QoL due to its relationship to
activities of daily living (Hagedoorn et al, 2002).
The results of this study suggest that early and intensive
nutrition support help minimise the reduction in global QoL and
physical function that generally accompanies radiotherapy. NI also
results in a faster improvement in global QoL and physical
function. This is supported by trials by Jamieson et al (1997) and
Tchekmedyian et al (2003, abstract), who observed a relationship
between nutrition support, weight gain and improved QoL.
However, there are several studies that have not found an increase
in QoL with weight maintenance or gain (Saunders et al, 1991;
Ovesen et al, 1993; Keele et al, 1997).
Limitations
A potential limitation of this study is that there was no true control
group and that those receiving UC still received an intervention,
although this was less intensive compared with the NI. The higher
than anticipated s.e.m. for changes in body weight reflects the
heterogeneous nature of subjects’ nutritional status, which ranged
from severely malnourished to obese. However, even with the large
s.e.m. the differences in body weight over time between the groups
were significant. The lack of long-term follow-up is a limitation of
the study and it is recommended that future studies investigate
longer-term morbidity and mortality data.
CONCLUSIONS
Early and intensive NI provides beneficial outcomes in terms of
minimising weight loss, deterioration in nutritional status, global
QoL and physical function in ambulatory oncology patients
receiving radiotherapy to the GI or head and neck area. Weight
maintenance in this population leads to beneficial outcomes and
suggests that this, rather than weight gain, may be a more
appropriate aim of nutrition support during radiotherapy.
Implications for practice
Patients at risk of malnutrition, such as those receiving radio-
therapy to the GI or head and neck area, should receive regular and
individualised nutrition support that continues postradiotherapy
as required. Where staff levels are not sufficient to allow for this
level of nutrition implementation, it is recommended that screen-
ing and triage systems be implemented to ensure that those clients
most in need of care receive a level that demonstrates outcomes.
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